Hyperhomocysteinemia induced by feeding rats diets rich in dl-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure

Vascular Pharmacology

Volumn 51, Issue 4, 2009, Pages 291-298

  de Andrade, Claudia Roberta ^a   Tirapelli, Carlos Renato ^a   Haddad, Renato ^b   Eberlin, Marcos N ^b   Ramalho, Leandra N Z ^a   Iyomasa, Mamie M ^a   Uyemura, Sergio A ^c   de Oliveira, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Depto Anal Clin Toxicol/B   (Brazil)

Author keywords

Acetylcholine; Endothelin 1; Hyperhomocysteinemia; Media layer; Phenylephrine; Rat carotid artery; Vascular responsiveness

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLEPHRINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CELL DENSITY; CHOLESTEROL BILE LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HYPERHOMOCYSTEINEMIA; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTAKE; RAT; SMOOTH MUSCLE CONTRACTILITY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; CAROTID ARTERIES; FEEDING METHODS; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MALE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION;

EID: 70349855181     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.07.004     Document Type: Article

References (41)

1. Accorsi-Mendonça D., Corrêa F.M.A., Paiva T.B., de Souza H.P., Laurindo F.R.M., and de Oliveira A.M. The balloon catheter induces an increase in contra-lateral carotid artery reactivity to angiotensin II and phenylephrine. Br. J. Pharmacol. 142 (2004) 79-88
2. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25 (1995) 155-161
3. Beauchamp M.C., and Renier G. Homocysteine induces protein kinase C activation and stimulates c-Fos and lipoprotein lipase expression in macrophages. Diabetes 51 (2002) 1180-1187
4. Blundell G., Jones B.G., Rose F.A., and Tudball N. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 122 (1996) 163-172
5. Bonaventura D., Tirapelli C.R., Haddad R., Höehr N.F., Eberlin M.N., and de Oliveira A.M. Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. Pharmacology 70 (2004) 91-99
6. Dalton M.L., Gadson P.F., Wrenn R.W., and Rosenquist T.H. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J. 11 (1997) 703-711
7. de Andrade C.R., Fukada S.Y., Olivon V.C., de Godoy M.A., Haddad R., Eberlin M.N., Cunha F.Q., de Souza H.P., Laurindo F.R., and de Oliveira A.M. Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur. J. Pharmacol. 543 (2006) 83-91
8. de Andrade C.R., Tirapelli C.R., Corrêa F.M., Ramalho L.N., and de Oliveira A.M. Total stenosis triggers compensatory responsiveness of carotid and basilar arteries to endothelin-1 and phenylephrine. Pharmacol. Res. 57 (2007) 32-42
9. de Andrade C.R., Leite P., Montezano A.C., Casolari D.A., Yogi A., Tostes R.C., Haddad R., Eberlin M.N., Laurindo F., Souza H.P., Correa F.M.A., and de Oliveira A.M. Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Brit. J. Pharmacol. 157 (2009) 568-580
10. Eller P., Schgoer W., Mueller T., Tancevski I., Wehinger A., Ulmer H., Foeger B., Haltmayer M., Ritsch A., and Patsch J.R. Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J. Intern. Med. 258 (2005) 344-348
11. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
12. Gryglewski R.J., Palmer R.M.J., and Moncada S. Superoxide anion is involved in the reakdown of endothelium-derived vascular relaxing factor. Nature 320 (1986) 454-456
13. Harker L.A., Ross R., Slichter S.J., and Scott C.R. Homocysteine induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58 (1976) 731-741
14. Hill C.H., Mecham R., and Starcher B. Fibrillin-2 defects impair elastic fiber assembly in a homocysteinemic chick model. J. Nutr. 132 (2002) 2143-2150
15. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9265-9269
16. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12 (1992) 279-298
17. Lang D., Kredan M.B., Moat S.J., Hussain S.A., Powell C.A., Bellamy M.F., Powers H.J., and Lewis M.J. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 422-427
18. Leoncini G., Pascale R., and Signorello M.G. Effects of homocysteine on l-arginine transport and nitric oxide formation in human platelets. Eur. J. Clin. Invest. 33 (2003) 713-719
19. Luscher T.F., Tanner F.C., Tschundi M.R., and Noll G. Endothelial dysfunction in coronary artery disease. Annu. Rev. Med. 44 (1993) 395-418
20. Majors A., Ehrhart L.A., and Pezacka E.H. Homocysteine as a risk factor for vascular disease: enhanced collagen production and accumulation by smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2074-2081
21. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56 (1969) 111-128
22. McCully K.S., and Carvalho A.C. Homocysteine thiolactone, N-homocysteine thiolactonyl retinamide, and platelet aggregation. Res. Commun. Chem. Pathol. Pharmacol. 56 (1987) 349-360
23. McCully K.S., Olszewski A.J., and Vezeridis M.P. Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. Atherosclerosis 83 (1990) 197-206
24. Miao C.Y., Villeneuve N., Brunel-Jacquemin C., Petit C., Guillaumin J.P., Gransagne D., Briant C., Vilaine J.P., and Vanhoutte P.M. Chronic mild hyperhomocysteinemia induces aortic endothelial dysfunction but does not elevate arterial pressure in rats. J. Vasc. Res. 42 (2005) 148-156
25. Mudd S.H., Finkelstein J.D., Refsum H., Ueland P.M., Malinow M.R., Lentz S.R., Jacobsen D.W., Brattström L., Wilcken B., Wilcken D.E.L., Blom H.J., Stabler S.P., Allen R.H., Selhub J., and Rosenberg I.H. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1704-1706
26. Nordestgaard B.G. The vascular endothelial barrier-selective retention of lipoproteins. Curr. Opin. Lipidol. 7 (1996) 269-273
27. O K, Lynn E.G., Chung Y.H., Siow Y.L., Man R.Y., and Choy P.C. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim. Biophys. Acta 1393 (1998) 317-324
28. Olszewski A.J., Szostak W.B., Bialkowska M., Rudnicki S., and McCully K.S. Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 75 (1989) 1-6
29. Ossani G.P., Fischer P.A., Caram S.G., Dominguez G.N., Monserrat A.J., and Masnatta L.D. Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats. Kidney Int. 66 (2004) 1866-1872
30. Papatheodorou L., and Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 9 (2007) 1941-1958
31. Perry D.J. Hyperhomocysteinemia. Baillière's Best Pract. Res. Clin. Haematol. 12 (1999) 451-477
32. Piolot A., Blache D., Boulet L., Fortin L.J., Dubreuil D., Marcoux C., Davignon J., and Lussier-Cacan S. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J. Lab. Clin. Med. 141 (2003) 41-49
33. Powers R.W., Majors A.K., Cerula S.L., Huber H.A., Schmidt B.P., and Roberts J.M. Changes in markers of vascular injury in response to transient hyperhomocysteinemia. Metabolism 52 (2003) 501-507
34. Raines E.W., and Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. 69 (1993) S30-S37
35. Refsum H., and Ueland P.M. Clinical significance of pharmacological modulation of homocysteine metabolism. Trends Pharmacol. Sci. 11 (1990) 411-416
36. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22 (1993) S1-S14
37. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
38. + Channels. Br. J. Pharmacol. 146 (2005) 903-912
39. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.M., Haber E., Schlegel R., and Lee M.E. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6369-6373
40. Ungvari Z., Pacher P., Rischak K., Szollar L., and Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1899-1904
41. Wall R.T., Harlan L.M., Harker L.A., and Striker G.E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18 (1980) 113-121